Dong Mengya, Liang Chenyuan, Cheng Gong
Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, Xi'an, China.
Front Cardiovasc Med. 2023 Sep 4;10:1154125. doi: 10.3389/fcvm.2023.1154125. eCollection 2023.
Cardiac resynchronization therapy (CRT) is a well-established method that improves the clinical symptoms and long-term prognosis of specific heart failure (HF) patients by restoring systolic synchronicity and enhancing myocardial function. However, the high rate of intraoperative and postoperative left ventricular (LV) lead dislocation limits its application to a great extent. The aim of this study was to demonstrate the long-term safety and effectiveness of a new approach named the loop technique for patients who experience repeated intraoperative transvenous LV lead dislocations during CRT.
The current study was a single-centre, prospective, nonrandomized controlled trial. Forty-four HF patients who underwent CRT were included. All patients were followed to death or 3 years.
Among 44 HF patients, 36 underwent the traditional operation, and 8 underwent the loop technique due to repeated intraoperative LV lead dislocations. Intergroup comparison revealed no significant differences between the two groups with respect to most preoperative indices, intraoperative pacing and sensing parameters. At the end of the 3-year follow-up, 4 (11.1%) patients in the traditional operation group and 2 (25.0%) patients in the loop technique group had died. There was no significant difference in the mortality rate ( = 0.30). No complications related to this new technique were observed, such as intracoronary thrombosis, infection or dislocation. Intergroup comparison showed no significant difference in the New York Heart Association (NYHA) class, echocardiography indices, N-terminal pro brain natriuretic peptide (NT-proBNP) level or pacemaker programming parameters.
The loop technique is a safe and effective alternative method for patients who experience repeated intraoperative transvenous LV lead dislocations during CRT.
心脏再同步治疗(CRT)是一种成熟的方法,通过恢复收缩同步性和增强心肌功能来改善特定心力衰竭(HF)患者的临床症状和长期预后。然而,术中及术后左心室(LV)导线脱位的高发生率在很大程度上限制了其应用。本研究的目的是证明一种名为环技术的新方法对在CRT期间术中反复经静脉LV导线脱位的患者的长期安全性和有效性。
本研究为单中心、前瞻性、非随机对照试验。纳入了44例行CRT的HF患者。所有患者均随访至死亡或3年。
44例HF患者中,36例行传统手术,8例因术中LV导线反复脱位而行环技术。组间比较显示,两组在大多数术前指标、术中起搏和感知参数方面无显著差异。在3年随访结束时,传统手术组有4例(11.1%)患者死亡,环技术组有2例(25.0%)患者死亡。死亡率无显著差异(=0.30)。未观察到与该新技术相关的并发症,如冠状动脉内血栓形成、感染或脱位。组间比较显示,纽约心脏协会(NYHA)分级、超声心动图指标、N末端脑钠肽前体(NT-proBNP)水平或起搏器程控参数无显著差异。
对于在CRT期间术中反复经静脉LV导线脱位的患者,环技术是一种安全有效的替代方法。